Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Andreasen

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Acta Neurologica Scandinavica|July 20, 2010
No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weaponsK Blennow, M Jonsson, N Andreasen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 19, 2001
Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's diseaseN Andreasen, J Gottfries, E Vanmechelen, et al.
Mechanisms of Ageing and Development|October 9, 2001
Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disordersE Vanmechelen, H Vanderstichele, F Hulstaert, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 21, 2012
Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitisSteen M Rønborg, Ulrik G Svendsen, Jesper S Micheelsen, et al.
Psychiatry Research|May 1, 1983
The reliability of retrospective treatment reportsM B Keller, P W Lavori, P McDonald-Scott, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 30, 2021
Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II studyTrine Ø Barkholt, Omeed Neghabat, Emil N Holck, et al.
Acta Neurologica Scandinavica|September 30, 2009
The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's diseaseE H Wiig, P Annas, H Basun, et al.
Archives of Neurology|June 16, 1999
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of diseaseN Andreasen, C Hesse, P Davidsson, et al.
Lakartidningen|March 27, 1996
[More accurate diagnosis could identify patients suitable for tacrine therapy]N Andreasen, S Eriksson, I Karlsson, et al.
Acta Neurologica Scandinavica|January 6, 2010
Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's diseaseK Wesnes, C Edgar, N Andreasen, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Acta Neurologica Scandinavica|July 20, 2010
No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weaponsK Blennow, M Jonsson, N Andreasen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 19, 2001
Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's diseaseN Andreasen, J Gottfries, E Vanmechelen, et al.
Mechanisms of Ageing and Development|October 9, 2001
Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disordersE Vanmechelen, H Vanderstichele, F Hulstaert, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 21, 2012
Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitisSteen M Rønborg, Ulrik G Svendsen, Jesper S Micheelsen, et al.
Psychiatry Research|May 1, 1983
The reliability of retrospective treatment reportsM B Keller, P W Lavori, P McDonald-Scott, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 30, 2021
Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II studyTrine Ø Barkholt, Omeed Neghabat, Emil N Holck, et al.
Acta Neurologica Scandinavica|September 30, 2009
The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's diseaseE H Wiig, P Annas, H Basun, et al.
Archives of Neurology|June 16, 1999
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of diseaseN Andreasen, C Hesse, P Davidsson, et al.
Lakartidningen|March 27, 1996
[More accurate diagnosis could identify patients suitable for tacrine therapy]N Andreasen, S Eriksson, I Karlsson, et al.
Acta Neurologica Scandinavica|January 6, 2010
Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's diseaseK Wesnes, C Edgar, N Andreasen, et al.
Pageof 8